AIM ImmunoTech (AIM) Net Margin Growth (5y) (2015 - 2026)
AIM ImmunoTech (AIM) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | AIM ImmunoTech | 4.50 Mn | -5.46 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -725,585.00 |
| Mar 31, 2026 | -81,883.00 |
| Dec 31, 2025 | -435,476.00 |
| Sep 30, 2025 | -86,517.00 |
| Jun 30, 2025 | -1.08 Mn |
| Mar 31, 2025 | -1.57 Mn |
| Dec 31, 2024 | -812,844.00 |
| Sep 30, 2024 | -787,766.00 |
| Jun 30, 2024 | -118,269.00 |
| Dec 31, 2023 | -2.06 Mn |
| Sep 30, 2023 | 114,577.00 |
| Jun 30, 2023 | -368,766.00 |
| Mar 31, 2023 | -434,311.00 |
| Dec 31, 2022 | -459,093.00 |
| Sep 30, 2022 | -2.92 Mn |
| Jun 30, 2022 | -1.49 Mn |
| Mar 31, 2022 | -629,989.00 |
| Dec 31, 2021 | 38.00 Mn |
| Sep 30, 2021 | -89,394.00 |
| Jun 30, 2021 | -178,928.00 |